“War in the Blood” is a 90-minute documentary aired on the 7th of July 2019 on BBC2 channel. It was produced by Minnow Films and directed by Arthur Carey. It features two investigators of ATECT – Martin Pule and Claire Roddie and follows two patients enrolled onto experimental phase I CAR T-cell clinical studies. One of the patients is recruited to the CARD study. The documentary shows the complex interplay between science teams, clinical teams and with the clinical trial subjects – the patients at the heart of the matter.
The ATECT consortium organized their general meeting in Zürich, on November 24th, 2016 at the facilities of Philogen Spa.
Partners engaged in an intensive one-day meeting to discuss the latest developments related to the technical and managerial aspects of the project.
Partners presented the work performed during the last project months and provided an update on the current task progress.
The steps to be followed in the coming months of the project were discussed by the partners, in order to submit the next periodic report to the European Commission and the ongoing amendment.
The ATECT consortium met in London on April 13th, 2016 at the offices of University College London.
Partners presented their work performed during the last project months and provided updates on current task progress.
The next project meeting will take place in November, 2016, in Zürich.
7th of January, 2014, Paris was the place selected for the kick-off meeting of the new and innovative FP7 project ATECT. CELLECTICS, the French partner based in Paris, organized the meeting and offered a welcome-dinner to the group.
ATECT is a 60 months project conformed by partners from UK, France, Italy, The Netherlands and Switzerland.
All rules regarding the FP7 Programme, the technical objectives of the project, the tasks that will lead the beneficiaries to their targets, were reviewed.
This first meeting helped the Consortium shape the technical agenda for other future meetings in order to meet all the challenges of the project on time.